Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates
Authors:
- Brett D. ThombsBTBrett D. Thombs
- Canadian Scleroderma Research GroupCGCanadian Scleroderma Research Group
Open Access
- 25 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 49 (4) , 789-796
Abstract
Objective. The reported rates of depressive symptoms in patients with SSc are high. The Center for Epidemiologic Studies Depression Scale (CES-D) is the only measure of depressive symptoms validated for SSc patients. The objective of this study was to assess the internal consistency reliability, convergent validity and strength of association with clinical correlates of the 9-item version of the Patient Health Questionnaire depression scale (PHQ-9) compared with the CES-D in SSc. Methods. We conducted a cross-sectional, multicentre study of 566 SSc patients who were assessed with the PHQ-9 and CES-D scales, and through clinical histories and medical examinations. Internal consistency reliability was assessed with Cronbach’s α, convergent validity with Pearson’s correlation and the relationship of socio-demographic and clinical variables with the PHQ-9 and CES-D scores using multiple linear regression. Results. Scale reliability was good for the PHQ-9 (α = 0.87) and similar to the CES-D (α = 0.90). Correlations of the PHQ-9 total score were −0.68 with mental health, −0.43 with physical health, 0.44 with disability, 0.40 with pain and 0.79 with fatigue, which were all in the expected direction and similar to the results with the CES-D. Regression coefficients of clinical correlates did not differ significantly between models using the PHQ-9 and CES-D. Conclusion. The PHQ-9 is reliable and valid for use as a measure of depressive symptom severity in patients with SSc and performs similarly to the CES-D. However, the PHQ-9 is advantageous because it is half the length of the CES-D, easily administered and scored, and is increasingly used across many patient groups for assessment in research and clinical settings.Keywords
This publication has 28 references indexed in Scilit:
- Health‐related quality of life in systemic sclerosis: A systematic reviewArthritis Care & Research, 2009
- Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: Evidence from a sample of 659 Canadian Scleroderma Research Group Registry patientsArthritis Care & Research, 2009
- Mental health in patients with systemic sclerosis: a controlled investigationJournal of the European Academy of Dermatology and Venereology, 2007
- Depression in patients with systemic sclerosis: A systematic review of the evidenceArthritis Care & Research, 2007
- Evaluation of depression and anxiety in patients with systemic sclerosisJoint Bone Spine, 2005
- Psychological adjustment to systemic sclerosis—exploring the association of disease factors, functional ability, body related attitudes and fear of negative evaluationPsychology, Health & Medicine, 2004
- Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US populationArthritis & Rheumatism, 2003
- Body image dissatisfaction among women with scleroderma: Extent and relationship to psychosocial function.Health Psychology, 2003
- The impact of pain and symptoms of depression in sclerodermaPain, 2002
- Depressive symptoms associated with sclerodermaArthritis & Rheumatism, 1996